Novavax completes process for WHO emergency use approval of COVID-19 vaccine

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photosaid on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.

The company is also expecting regulators in countries including India and the Philippines to decide on its vaccine within weeks.A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries.

Biden's Vaccine Mandate to begin in January Subscribe Like video Share MrInfluencerUg COVID19 Watch official video 👉

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

5- to 11-year-olds can now get a Covid-19 vaccine in the USVaccine advisers to the US Centers for Disease Control and Prevention voted unanimously Tuesday to recommend giving Pfizer's Covid-19 vaccine to children ages 5-11. Follow here for the latest news updates. Kids were pretty safe according to CDC data. But it’s more money for the big companies, so Jab them up!!!!! $$$ Joseph Melenge 2.0 They have a 99.9947% chance of survival without intervention Your Gene Therapy Experimental shot increases 2nd and 3rd order medical problems above the statistical background averages The Risk far and away exceeds the stated Reward DoNotComply
Source: cnnbrk - 🏆 393. / 55 Read more »